Physician specialising in Pharmaceutical Medicine with more than 10 years’ experience in medicines regulation, pharmacovigilance, health technology assessment, health economics and clinical research. Currently working in regulation nationally (Health Products Regulatory Authority) and at EU level (appointment to Pharmacovigilance Risk Assessment Committee of the European Medicines Agency) and a member of the Faculty of Pharmaceutical Medicine (RCP). Previously, over 5 years in senior roles within Health Technology Assessment leading national assessments on technologies such as medicines and vaccine programmes and completing PhD on the clinical and cost-effectiveness of a publicly funded HIV pre-exposure prophylaxis (PrEP) programme in Ireland, which received the Shani-Rushin Achievement Award from Trinity College Dublin (2017). This work contributed to formal HIQA advice underpinning the Irish Government’s decision to introduce a publicly funded national HIV PrEP programme in 2019. Contributed over 20 peer-reviewed publications (over 1,600 citations; i10-index 13), and awarded Top-Cited Author from Wiley in 2022. I have led academic collaborations to inform health policy both nationally to support Ireland’s response to COVID-19 and internationally (with the European Centre for Disease Prevention and Control) to inform EU influenza vaccine policy.